[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Inhaled Nitric Oxide Industry Research Report 2024

April 2024 | 113 pages | ID: I4FC0CA5A56CEN
APO Research

US$ 2,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

According to APO Research, the global Inhaled Nitric Oxide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

Mallinckrodt monopolizes the global Inhaled Nitric Oxide market, holding a share about 65%.

North America is the largest market, with a share about 77%, followed by Asia-Pacific and Europe, have a share about 20 percent.

In terms of product, 800 ppm is the largest segment, with a share over 50%. And in terms of application, the largest application is Near-term and Pre-term Infants PPHN, followed by Children and Adult ARDS, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Inhaled Nitric Oxide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Nitric Oxide.

The report will help the Inhaled Nitric Oxide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Inhaled Nitric Oxide market size, estimations, and forecasts are provided in terms of sales volume (M L) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inhaled Nitric Oxide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • Mallinckrodt
  • Praxair (Linde plc)
  • Air Liquide
  • BOC Healthcare (Linde Group)
Inhaled Nitric Oxide segment by Type
  • 800 ppm
  • 100 ppm
  • Others
Inhaled Nitric Oxide segment by Application
  • Near-term and Pre-term Infants PPHN
  • Children and Adult ARDS
  • Other Diseases
Inhaled Nitric Oxide Segment by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaled Nitric Oxide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhaled Nitric Oxide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaled Nitric Oxide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Inhaled Nitric Oxide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Inhaled Nitric Oxide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Inhaled Nitric Oxide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

Chapter 11: The main points and conclusions of the report.
1 PREFACE

1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
  1.5.1 Secondary Sources
  1.5.2 Primary Sources

2 MARKET OVERVIEW

2.1 Product Definition
2.2 Global Market Growth Prospects
  2.2.1 Global Inhaled Nitric Oxide Market Size (2019-2030) & (US$ Million)
  2.2.2 Global Inhaled Nitric Oxide Sales (2019-2030)
  2.2.3 Global Inhaled Nitric Oxide Market Average Price (2019-2030)
2.3 Inhaled Nitric Oxide by Type
  2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
  2.3.2 800 ppm
  2.3.3 100 ppm
  2.3.4 Others
2.4 Inhaled Nitric Oxide by Application
  2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
  2.4.2 Near-term and Pre-term Infants PPHN
  2.4.3 Children and Adult ARDS
  2.4.4 Other Diseases

3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS

3.1 Global Inhaled Nitric Oxide Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Inhaled Nitric Oxide Sales (M L) of Manufacturers (2019-2024)
3.3 Global Inhaled Nitric Oxide Revenue of Manufacturers (2019-2024)
3.4 Global Inhaled Nitric Oxide Average Price by Manufacturers (2019-2024)
3.5 Global Inhaled Nitric Oxide Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Inhaled Nitric Oxide, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Inhaled Nitric Oxide, Product Type & Application
3.8 Global Manufacturers of Inhaled Nitric Oxide, Date of Enter into This Industry
3.9 Global Inhaled Nitric Oxide Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition

4 MANUFACTURERS PROFILED

4.1 Mallinckrodt
  4.1.1 Mallinckrodt Company Information
  4.1.2 Mallinckrodt Business Overview
  4.1.3 Mallinckrodt Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2019-2024)
  4.1.4 Mallinckrodt Inhaled Nitric Oxide Product Portfolio
  4.1.5 Mallinckrodt Recent Developments
4.2 Praxair (Linde plc)
  4.2.1 Praxair (Linde plc) Company Information
  4.2.2 Praxair (Linde plc) Business Overview
  4.2.3 Praxair (Linde plc) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2019-2024)
  4.2.4 Praxair (Linde plc) Inhaled Nitric Oxide Product Portfolio
  4.2.5 Praxair (Linde plc) Recent Developments
4.3 Air Liquide
  4.3.1 Air Liquide Company Information
  4.3.2 Air Liquide Business Overview
  4.3.3 Air Liquide Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2019-2024)
  4.3.4 Air Liquide Inhaled Nitric Oxide Product Portfolio
  4.3.5 Air Liquide Recent Developments
4.4 BOC Healthcare (Linde Group)
  4.4.1 BOC Healthcare (Linde Group) Company Information
  4.4.2 BOC Healthcare (Linde Group) Business Overview
  4.4.3 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2019-2024)
  4.4.4 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product Portfolio
  4.4.5 BOC Healthcare (Linde Group) Recent Developments

5 GLOBAL INHALED NITRIC OXIDE MARKET SCENARIO BY REGION

5.1 Global Inhaled Nitric Oxide Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Inhaled Nitric Oxide Sales by Region: 2019-2030
  5.2.1 Global Inhaled Nitric Oxide Sales by Region: 2019-2024
  5.2.2 Global Inhaled Nitric Oxide Sales by Region: 2025-2030
5.3 Global Inhaled Nitric Oxide Revenue by Region: 2019-2030
  5.3.1 Global Inhaled Nitric Oxide Revenue by Region: 2019-2024
  5.3.2 Global Inhaled Nitric Oxide Revenue by Region: 2025-2030
5.4 North America Inhaled Nitric Oxide Market Facts & Figures by Country
  5.4.1 North America Inhaled Nitric Oxide Market Size by Country: 2019 VS 2023 VS 2030
  5.4.2 North America Inhaled Nitric Oxide Sales by Country (2019-2030)
  5.4.3 North America Inhaled Nitric Oxide Revenue by Country (2019-2030)
  5.4.4 U.S.
  5.4.5 Canada
5.5 Europe Inhaled Nitric Oxide Market Facts & Figures by Country
  5.5.1 Europe Inhaled Nitric Oxide Market Size by Country: 2019 VS 2023 VS 2030
  5.5.2 Europe Inhaled Nitric Oxide Sales by Country (2019-2030)
  5.5.3 Europe Inhaled Nitric Oxide Revenue by Country (2019-2030)
  5.5.4 Germany
  5.5.5 France
  5.5.6 U.K.
  5.5.7 Italy
  5.5.8 Russia
5.6 Asia Pacific Inhaled Nitric Oxide Market Facts & Figures by Country
  5.6.1 Asia Pacific Inhaled Nitric Oxide Market Size by Country: 2019 VS 2023 VS 2030
  5.6.2 Asia Pacific Inhaled Nitric Oxide Sales by Country (2019-2030)
  5.6.3 Asia Pacific Inhaled Nitric Oxide Revenue by Country (2019-2030)
  5.6.4 China
  5.6.5 Japan
  5.6.6 South Korea
  5.6.7 India
  5.6.8 Australia
  5.6.9 China Taiwan
  5.6.10 Indonesia
  5.6.11 Thailand
  5.6.12 Malaysia
5.7 Latin America Inhaled Nitric Oxide Market Facts & Figures by Country
  5.7.1 Latin America Inhaled Nitric Oxide Market Size by Country: 2019 VS 2023 VS 2030
  5.7.2 Latin America Inhaled Nitric Oxide Sales by Country (2019-2030)
  5.7.3 Latin America Inhaled Nitric Oxide Revenue by Country (2019-2030)
  5.7.4 Mexico
  5.7.5 Brazil
  5.7.6 Argentina
5.8 Middle East and Africa Inhaled Nitric Oxide Market Facts & Figures by Country
  5.8.1 Middle East and Africa Inhaled Nitric Oxide Market Size by Country: 2019 VS 2023 VS 2030
  5.8.2 Middle East and Africa Inhaled Nitric Oxide Sales by Country (2019-2030)
  5.8.3 Middle East and Africa Inhaled Nitric Oxide Revenue by Country (2019-2030)
  5.8.4 Turkey
  5.8.5 Saudi Arabia
  5.8.6 UAE

6 SEGMENT BY TYPE

6.1 Global Inhaled Nitric Oxide Sales by Type (2019-2030)
  6.1.1 Global Inhaled Nitric Oxide Sales by Type (2019-2030) & (M L)
  6.1.2 Global Inhaled Nitric Oxide Sales Market Share by Type (2019-2030)
6.2 Global Inhaled Nitric Oxide Revenue by Type (2019-2030)
  6.2.1 Global Inhaled Nitric Oxide Sales by Type (2019-2030) & (US$ Million)
  6.2.2 Global Inhaled Nitric Oxide Revenue Market Share by Type (2019-2030)
6.3 Global Inhaled Nitric Oxide Price by Type (2019-2030)

7 SEGMENT BY APPLICATION

7.1 Global Inhaled Nitric Oxide Sales by Application (2019-2030)
  7.1.1 Global Inhaled Nitric Oxide Sales by Application (2019-2030) & (M L)
  7.1.2 Global Inhaled Nitric Oxide Sales Market Share by Application (2019-2030)
7.2 Global Inhaled Nitric Oxide Revenue by Application (2019-2030)
  7.2.1 Global Inhaled Nitric Oxide Sales by Application (2019-2030) & (US$ Million)
  7.2.2 Global Inhaled Nitric Oxide Revenue Market Share by Application (2019-2030)
7.3 Global Inhaled Nitric Oxide Price by Application (2019-2030)

8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET

8.1 Inhaled Nitric Oxide Value Chain Analysis
  8.1.1 Inhaled Nitric Oxide Key Raw Materials
  8.1.2 Raw Materials Key Suppliers
  8.1.3 Inhaled Nitric Oxide Production Mode & Process
8.2 Inhaled Nitric Oxide Sales Channels Analysis
  8.2.1 Direct Comparison with Distribution Share
  8.2.2 Inhaled Nitric Oxide Distributors
  8.2.3 Inhaled Nitric Oxide Customers

9 GLOBAL INHALED NITRIC OXIDE ANALYZING MARKET DYNAMICS

9.1 Inhaled Nitric Oxide Industry Trends
9.2 Inhaled Nitric Oxide Industry Drivers
9.3 Inhaled Nitric Oxide Industry Opportunities and Challenges
9.4 Inhaled Nitric Oxide Industry Restraints

10 REPORT CONCLUSION

11 DISCLAIMER



More Publications